Abstract
Present situation of Japanese pharmaceutical companies has been analyzed by various statistics, and compared with the situation in the world. The environment of pharmaceutical industries are rapidly changing in its structure, worldwide regulatory viewpoints, and the trend of globalization. (1) Out-sourcing or contract specialized business are emerging rapidly in every field of pharmaceutical industries, such as research and development, manufacturing and even in the field of sales and promotion, According to the emerging of such contract or specialized organization in each function of the industries, importance of quality unit should be emphasized as a key function which has the responsibility for the branded products. (2) How to make use of these specialized other functions would play an important role for the success of future pharmaceutical industry. (3) For the globalization of Japanese pharmaceutical industries, not only the development of new products, regulatory issues, patent, G“X”P, and relation with alliance would be important, since there have been so many Japanese industries who had experienced same kinds of problems in launching their product. (4) Foreign affiliated pharmaceutical industries in Japan, they are steadily progressing their business by introducing new products and sales promotion. (5) Generic products should be more widely used in Japan from the view points of cost effective medical treatment in comparison with other countries.